Skip to main content
. 2018 Mar 7;19(3):752. doi: 10.3390/ijms19030752

Figure 5.

Figure 5

Combined BTLA and ZBTB16 expression predict mammary carcinoma patient survival. The METABRIC dataset (Curtis et al., 2012) was analyzed concerning a correlation of the NKT cells lineage determining transcription factor ZBTB16 and BTLA with overall survival. (A) Survival rates of patients expressing high (>75% percentile) or lower (<75% percentile) levels of ZBTB16. (B) Survival rates of patients expressing high (>75% percentile) levels of ZBTB16 after further separation into groups expressing high (>75% percentile) or lower (<75% percentile) levels of BTLA. p-values were calculated using log-rank test.